These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21455861)

  • 21. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.
    van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Büller HR; Meijer K
    Blood; 2011 Aug; 118(8):2055-61; quiz 2375. PubMed ID: 21659542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
    Federici EH; Al-Mondhiry H
    Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.
    van Vlijmen EF; Veeger NJ; Middeldorp S; Hamulyák K; Prins MH; Kluin-Nelemans HC; Meijer K
    J Thromb Haemost; 2016 Sep; 14(9):1741-8. PubMed ID: 27327043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
    Saemundsson Y; Sveinsdottir SV; Svantesson H; Svensson PJ
    J Thromb Thrombolysis; 2013 Oct; 36(3):324-31. PubMed ID: 23054468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study.
    Salim S; Zarrouk M; Elf J; Gottsäter A; Sveinsdottir S; Svensson P; Acosta S
    J Thromb Thrombolysis; 2019 May; 47(4):572-577. PubMed ID: 30756343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor V Leiden: how great is the risk of venous thromboembolism?
    Shaheen K; Alraies MC; Alraiyes AH; Christie R
    Cleve Clin J Med; 2012 Apr; 79(4):265-72. PubMed ID: 22473726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombophilia in women with pregnancy-associated complications: fetal loss and pregnancy-related venous thromboembolism.
    Kovac M; Mitic G; Mikovic Z; Djordjevic V; Savic O; Mandic V; Rakicevic LJ; Antonijevic N; Radojkovic D
    Gynecol Obstet Invest; 2010; 69(4):233-238. PubMed ID: 20068329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between pre-eclampsia and inherited thrombophilias.
    Deveer R; Engin-Ustun Y; Akbaba E; Halisdemir B; Cakar E; Danisman N; Mollamahmutoglu L; Yesilyurt A; Candemir Z
    Fetal Pediatr Pathol; 2013 Jun; 32(3):213-7. PubMed ID: 23002795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
    Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
    J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of factor V Leiden: clinical implications.
    De Stefano V; Chiusolo P; Paciaroni K; Leone G
    Semin Thromb Hemost; 1998; 24(4):367-79. PubMed ID: 9763354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placement of a vena cava filter in term pregnancy: case report and review of the literature.
    Zeybek B; Terek MC; Guven C; Cinar C
    Clin Exp Obstet Gynecol; 2011; 38(1):96-8. PubMed ID: 21485739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.